PARSIPPANY, N.J., Nov. 21, 2011 /PRNewswire/ -- Switzerland-based Ferring Pharmaceuticals today announced the purchase of a 25-acre site at 100 Interpace Parkway in Parsippany, N.J. The new facility ...

New facility underscores long-term commitment to the U.S. and to New Jersey Parsippany, NJ, USA, 4 December 2014 – Ferring Pharmaceuticals has expanded its footprint in New Jersey with the opening of ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced that Aaron Graff has been appointed Chief Executive Officer of Ferring Holding Inc. In this role Mr. Graff assumes direct ...

Ferring Pharmaceuticals is expanding its capabilities in biologics through a new biotech center to be built at the company’s existing headquarters and manufacturing site in Saint-Prex, Switzerland.

Antares Pharma, Inc. (NYSE Amex: AIS) today announced the simultaneous signing of a license and an asset purchase agreement with Ferring International Center S.A. Under the terms of the exclusive ...

Ferring Pharmaceuticals and Posterity Health, a male fertility center of excellence, have partnered to launch a male fertility program. The two organizations announced the program’s debut on Thursday ...

This March of Dimes Prematurity Research Center at Imperial College London is supported by a grant from Ferring Pharmaceuticals. Both Ferring and March of Dimes are committed to advancing research to ...

Ferring Pharmaceuticals said today it will partner with the Karolinska Institutet to establish a research center that will carry out translational research on the human microbiome. The value of the ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...